Sepsis is a life-threatening condition that requires extensive medical management. But despite best efforts, the death rate continues to be high.
A clinical trial has investigated the effect of using a provider and pharmacist in the emergency department for the optimum administration of life-saving antibiotics.
Sepsis is a serious condition that occurs when the body's response to infection becomes dysregulated, leading to damage to multiple organ systems and potentially resulting in death. Prompt administration of antibiotics is critical in the treatment of sepsis, and delays in treatment can lead to poor outcomes for patients.
As medical technology and knowledge continue to advance, constant breakthroughs are being made to improve patient outcomes. One such breakthrough is using a provider and pharmacist-facing sepsis early warning system in emergency departments, which has been shown to significantly improve the timeliness of antibiotic administration.
The study has shed light on the results of a clinical trial aimed at implementing such a system in emergency departments.
Clinical TrialThe clinical trial involved 598 patients who presented to the emergency department of a hospital over 5 months. These patients were divided into two groups. 285 patients received augmented care with a provider and pharmacist while 313 patients received standard sepsis care. Time to antibiotic administration from arrival was measured in all these patients.
The clinical study aimed to evaluate the effectiveness of a sepsis early warning system that alerts healthcare providers and pharmacists to potential cases of sepsis so that they can take action quickly. The system uses electronic health record data to identify patients who meet certain criteria indicating a high risk of sepsis. The alerts are then sent to providers and pharmacists via a secure messaging system, allowing for quick action to be taken.